Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Genmab A/S
  6. News
  7. Summary
    GMAB   DK0010272202

GENMAB A/S

(GMAB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about GENMAB A/S
10/15GENMAB A/S : Announces that Janssen has Received Positive CHMP Opinion for RYBREVANT« (ami..
AQ
10/07GENMAB A/S : Grant of Restricted Stock Units and Warrants to Employees in Genmab (Form 6-K..
PU
10/07GENMAB A/S : Grant of Restricted Stock Units and Warrants to Employees in Genmab
AQ
10/07GENMAB A/S : Articles of Association dated October 7, 2021 – English
PU
10/01GENMAB : Announces Abstracts Evaluating Investigational Solid Tumor Therapies to be Presen..
BU
10/01Genmab Announces Abstracts Evaluating Investigational Solid Tumor Therapies to be Prese..
CI
09/27GENMAB A/S : RBC Lifts Price Target on Genmab to $56 From $55 Amid Tivdak US Approval, Pot..
MT
09/22GENMAB A/S : (English translation of Articles of Association) (Form 6-K)
PU
09/22GENMAB A/S : Articles of association dated September 21, 2021 – English
PU
09/22GENMAB A/S : Investor Presentation - September 2021
PU
09/21GENMAB A/S : Capital Increase in Genmab as a Result of Employee Warrant Exercise (Form 6-K..
PU
09/21Capital Increase in Genmab as a Result of Employee Warrant Exercise
GL
09/20GENMAB A/S : TIVDAK is a First-in-Class Antibody-Drug Conjugate Directed to Tissue Factor,..
PU
09/20GENMAB A/S : and Seagen Announce FDA Accelerated Approval for TIVDAK™ (tisotumab ved..
AQ
09/19GENMAB A/S : and Seagen Present Interim Results From the innovaTV 205 Study for Tisotumab ..
AQ
More most relevant news
All news about GENMAB A/S
10/15GENMAB A/S : Announces that Janssen has Received Positive CHMP Opinion for RYBREVANT« (ami..
AQ
10/07GENMAB A/S : Grant of Restricted Stock Units and Warrants to Employees in Genmab (Form 6-K..
PU
10/07GENMAB A/S : Grant of Restricted Stock Units and Warrants to Employees in Genmab
AQ
10/07GENMAB A/S : Articles of Association dated October 7, 2021 – English
PU
10/04PRESS RELEASE : Pfizer and BioNTech Receive CHMP -2-
DJ
10/01PRESS RELEASE : BioNTech to Present New Clinical and Preclinical Data Across Multiple Immu..
DJ
10/01GENMAB : Announces Abstracts Evaluating Investigational Solid Tumor Therapies to be Presen..
BU
10/01Genmab Announces Abstracts Evaluating Investigational Solid Tumor Therapies to be Prese..
CI
10/01PRESS RELEASE : BioNTech Expands Clinical Oncology Portfolio with First Patient Dosed in P..
DJ
09/27GENMAB A/S : RBC Lifts Price Target on Genmab to $56 From $55 Amid Tivdak US Approval, Pot..
MT
More news
News in other languages on GENMAB A/S
10/04GlobeNewswire/Pfizer und BioNTech erhalten -3-
10/01GlobeNewswire/BioNTech präsentiert neue klinische und präklinische Daten aus mehreren I..
10/01GLOBENEWSWIRE/BIONTECH ERWEITERT KLI : Erster Patient in Phase 2-Studie mit individualisie..
09/22GlobeNewswire/Pfizer und BioNTech erweitern -3-
09/20Seagen et Genmab obtiennent l'autorisation accélérée de la FDA pour le Tivdak dans le t..
09/20GlobeNewswire/Pfizer und BioNTech geben positive -4-
09/18GlobeNewswire/FDA-Beratungsausschuss unterstützt -4-
09/16AVIS D'ANALYSTES DU JOUR : Air France KLM, Eurofins, Infineon, Idorsia, Ab Inbev, Getlink,..
09/16OPINIÓN DE LOS ANALISTAS DEL DÍA : Caixabank, Banco Santander, Unicredit, Idorsia, Ab Inbe..
09/09The Lancet publie les résultats positifs de l'essai de phase 1/2 d'Epcoritamab de Genma..
More news
Analyst Recommendations on GENMAB A/S
09/27GENMAB A/S : RBC Lifts Price Target on Genmab to $56 From $55 Amid Tivdak US Approval, Pot..
MT
09/16GENMAB A/S : Jefferies & Co Downgrades Genmab A/S to Hold From Buy
MT
09/07GENMAB A/S : Morgan Stanley Downgrades Genmab to Underweight from Equalweight, Keeps $37 P..
MT
08/24GENMAB A/S : HC Wainwright Downgrades Genmab to Neutral From Buy
MT
08/12GENMAB A/S : RBC Raises Price Target on Genmab to $55 From $46, Citing Q2 Strength, 2021 G..
MT
More recommendations
Press releases
10/15GENMAB A/S : Announces that Janssen has Received Positive CHMP Opinion for RYBREVANT« (ami..
AQ
10/07GENMAB A/S : Grant of Restricted Stock Units and Warrants to Employees in Genmab (Form 6-K..
PU
10/07GENMAB A/S : Grant of Restricted Stock Units and Warrants to Employees in Genmab
AQ
10/07GENMAB A/S : Articles of Association dated October 7, 2021 – English
PU
10/01GENMAB : Announces Abstracts Evaluating Investigational Solid Tumor Therapies to be Presen..
BU
More press releases
Upcoming event on GENMAB A/S